Vitiligo and cutaneous malignancy: what is the risk?
Vitiligo is a disorder of depigmentation affecting up to two percent of the global population. It is a long-held belief that patients with vitiligo have an increased risk for skin cancers due to the loss of melanin, a pigment which protects the skin against carcinogenesis. Phototherapy, a mainstay t...
Saved in:
Main Authors: | Sahngeun Jenny Mun, Monisha Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Pigment International |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/pigmentinternational_28_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phototherapy in vitiligo
by: Anuradha Bishnoi, et al.
Published: (2024-12-01) -
Vitiligo treatment: a literature review
by: Monika J. Leżanko, et al.
Published: (2025-01-01) -
Sinonasal malignancies: histopathological entities, regional involvement and long-term outcome
by: Lukas Anschuetz, et al.
Published: (2023-04-01) -
Nevoid basal cell carcinoma syndrome (Gorlin syndrome): a case report
by: Noura Abdul Rahman, et al.
Published: (2025-01-01) -
Sebaceous carcinoma with apocrine differentiation arising in a known case of basal cell carcinoma: A rare entity
by: Manisha Ahuja, et al.
Published: (2023-01-01)